GLIACURE, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.gliacure.com
Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2015-03-11
- Last Posted Date
- 2016-02-03
- Lead Sponsor
- GliaCure, Inc.
- Target Recruit Count
- 39
- Registration Number
- NCT02386306
- Locations
- 🇺🇸
Collaborative Neuroscience Network, Long Beach, California, United States
🇺🇸Quantum laboratories / Memory Disorder Center, Deerfield Beach, Florida, United States
🇺🇸MD Clinical, Hallandale Beach, Florida, United States
Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects
- First Posted Date
- 2014-10-01
- Last Posted Date
- 2015-02-18
- Lead Sponsor
- GliaCure, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT02254369
- Locations
- 🇺🇸
Celerion, Neptune, New Jersey, United States